Macrocycles and Constrained Peptides

2019-10-09T10:20:57-08:00April 11th, 2013|on Macrocycles, Publications|

Macrocycles and constrained peptides have undergone a rebirth over the last five years in drug discovery, due mainly to the introduction of new approaches for their synthesis and screening. This scientific progress has fueled a burst of business activity, with at least 12 biotech companies in the space, of which almost half were founded in the last 5 years.
Read online article